FTC Files Amicus Brief in Sage Chemical Vs. Supernus Pharmaceutical
March 22, 2023
March 22, 2023
WASHINGTON, March 22 -- The Federal Trade Commission issued the following news release:
The Federal Trade Commission filed a brief as Amicus Curiae in the U.S. District Court for the District of Delaware in a case related to Sage Chemical Inc. and its marketing partner TruPharma, LLC's efforts to sell a lower-cost alternative to Apokyn. Apokyn is an injectable drug used to treat patients with symptoms of advanced Parkinson's Disease. Apokyn's cost per patient to the M . . .
The Federal Trade Commission filed a brief as Amicus Curiae in the U.S. District Court for the District of Delaware in a case related to Sage Chemical Inc. and its marketing partner TruPharma, LLC's efforts to sell a lower-cost alternative to Apokyn. Apokyn is an injectable drug used to treat patients with symptoms of advanced Parkinson's Disease. Apokyn's cost per patient to the M . . .